The effect of smoking on the activity of inflammatory markers in patients with COPD Source: Annual Congress 2013 –Tobacco use in different countries: crisis to disease Year: 2013
Different changes in plasma concentrations of cytokines and chemokines in patients with COPD associated with smoking and occupational exposures Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes Year: 2016
Genetic differences in COPD secondary to wood smoke and tobacco smoking Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013
Differences in the polarization of the inflammatory response of patients with chronic obstructive pulmonary disease (COPD) secondary to smoking and to biomass smoke exposure Source: Annual Congress 2013 –COPD: new markers of diseases Year: 2013
Lack of association between increased mitochondrial DNA 4977 deletion and ATP levels of sputum cells from chronic obstructive pulmonary disease patients versus healthy smokers Source: International Congress 2014 – Passive smoking, active smoking and COPD Year: 2014
Susceptibility to tobacco smoke related to protease inhibitor PIM subtypes in COPD Source: Annual Congress 2005 - What's new in tobacco and lung disease Year: 2005
Reduced airway expression of cytoprotective CC10 in COPD patients and mice exposed to cigarette smoke Source: Annual Congress 2013 –COPD: experimental biology Year: 2013
Haplotypes associated with COPD and its severity in Mexican mestizo population Source: Annual Congress 2013 –Genetics and genomics of lung disease Year: 2013
Cigarette smoke alters the EZH2/DAB2IP expression in bronchial epithelial cells. A risk factor for lung cancer in COPD patients Source: International Congress 2016 – Studies in airway cell biology Year: 2016
Comparison of serum cytokine profiles among biomass- and tobacco smoke induced chronic obstructive pulmonary disease (COPD) patients in a South Indian population: A pilot study Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction Year: 2017
Ninety seven independent genomic signals for lung function predict susceptibility to moderate to severe COPD Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD Year: 2016
Novel genes associated with the level of FEV1 in never-smokers in the context of occupational exposure Source: International Congress 2015 – Genetics, genomics and exposures in asthma and COPD Year: 2015
Implication of interleukin-10 in the development of COPD induced by cigarette smoke exposure in mice Source: Annual Congress 2013 –COPD: experimental biology Year: 2013
Polymorphic variants of genes ADRB2, NR3C1, MDR1 in patients with chronic obstructive pulmonary disease and obesity Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD Year: 2015
Differences in microsatellite DNA level between asthma and chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: 472-478 Year: 2006
Smoking, genotype and gene expression levels in COPD Source: International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome Year: 2014
VNTR polymorphism in IL1RN gene in COPD and bronchial astma in Bulgarian population Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013
Characterization and functional progression of COPD in young adults (early COPD) Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013
Genes, the environment and the lung Source: Annual Congress 2006 - Genes, environment and the lung Year: 2006
Elevated circulating CTLA-4 level in patients with COPD is related to systemic inflammation and disease severity Source: Annual Congress 2013 –COPD: markers and inflammation Year: 2013